Identifying and Optimizing Novel Nucleases for CRISPR-Based Therapies

Time: 9:00 am
day: Day One


  • Understand how best to investigate different novel nucleases for specific disease modalities
  • Evaluating how to use protein engineering to optimize their activity, specificity and safety profiles
  • Highlighting the flexibility novel nucleases bring to vector delivery method choice